Search
for
Sort by
Research 721–750 of 1000+
- Development of Novel Drug Delivery Systems for the Treatment of Alopecia
- Alopecia Areata after Omalizumab Treatment for Chronic Spontaneous Urticaria
- Faculty Opinions recommendation of Six novel susceptibility Loci for early-onset androgenetic alopecia and their unexpected association with common diseases.
- Faculty Opinions recommendation of Six novel susceptibility Loci for early-onset androgenetic alopecia and their unexpected association with common diseases.
- Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review
- Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024
- The impact of obesity on the folliculosebaceous unit
- JAK1 gain-of-function variant causes alopecia areata, atopic dermatitis, and autoimmune thyroid disease
- Adjunctive Dupilumab Therapy in a Partial Responder to Baricitinib for Alopecia Areata
- 50832 Confetti variant of Alopecia Areata: A Single Center Retrospective Study to Describe a Novel Entity
- Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
- Caída capilar: nuevos factores causales y nuevos principios activos para un abordaje más integral con complementos alimenticios
- No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study
- New and Emerging Therapies for Alopecia Areata
- Platelet-Rich Plasma: Evolving Role in Plastic Surgery
- Skin Manifestations of Targeted Antineoplastic Therapy
- 76976 Association of Depression with Finasteride Stratified by Dosage and Diagnosis: A Retrospective Cohort Study Using the TriNetX Database
- Platelet-Rich Plasma in Androgenetic Alopecia: Is It Really Worth the Hype?
- Case Report of Tinea Capitis Caused by Combined Microsporum audouinii and Microsporum canis
- Baricitinib for the Treatment of Alopecia Areata
- Novel drugs of United States Food and Drug Administration approved in 2024
- A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- The “Science of Aging, Part 2” Supplement
- Alopecia Areata and Dexamethasone Mini-Pulse Therapy, A Prospective Cohort: Real World Evidence and Factors Related to Successful Response
- Epidermal growth factor, innovation and safety
- Concomitant occurrence of acneiform eruption, alopecia areata, and urticaria during adalimumab treatment in a patient with pustulosis palmoplantaris: Case report and literature review
- Netherton syndrome: effect on ichthyosis linearis circumflexa with dupilumab
- Comparative Efficacy of JAK Inhibitors in Acute vs Nonacute Alopecia Areata: A Retrospective Cohort Study
- Real-life effectiveness and safety of baricitinib in 17 Japanese patients with alopecia areata: a 60-week single center study